Adaptyv

We're building fully automated labs for protein engineering

Lausanne, Switzerland · $10.8M raised

Headquarters
Lausanne
Employees
11–50
Total Funding
$10.8M
Last Round
$8.0M SeedJan 2024
Rounds
3

About

Proteins are the most advanced nanotechnology we know of. At Adaptyv, we’re building a fully automated protein foundry to allow you to synthesize and test any protein you design.

Summary

Adaptyv is a Drug Discovery company based in Lausanne, Switzerland. It has raised $10.8M in total across 3 rounds, most recently a $8.0M Seed round in Jan 2024. Investors include ACE Ventures, Wingman Ventures and Y Combinator Continuity Fund.

Tech & App Stack

15 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

SeedSeed RoundJan 2024
$8.0M

Sign up to see all 3 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies